188 related articles for article (PubMed ID: 32884242)
1. Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy.
Zhang X; Deng Y; Xiang J; Liu H; Zhang J; Liao J; Chen K; Liu B; Liu J; Pu Y
Drug Des Devel Ther; 2020; 14():3393-3405. PubMed ID: 32884242
[TBL] [Abstract][Full Text] [Related]
2. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet.
Wang C; Yang F; Zeng W; Chen X; Qiu Z; Wang Q; Meng Y; Zheng G; Hu J
J Food Sci; 2024 May; 89(5):3019-3036. PubMed ID: 38517018
[TBL] [Abstract][Full Text] [Related]
3. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
4. PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy.
Kim BM; Kim DH; Park YJ; Ha S; Choi YJ; Yu HS; Chung KW; Chung HY
J Nutr Biochem; 2021 Sep; 95():108769. PubMed ID: 34000413
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet.
Liou CJ; Lee YK; Ting NC; Chen YL; Shen SC; Wu SJ; Huang WC
Cells; 2019 May; 8(5):. PubMed ID: 31083505
[TBL] [Abstract][Full Text] [Related]
6. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
7. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
8. 1,25(OH)
Li R; Guo E; Yang J; Li A; Yang Y; Liu S; Liu A; Jiang X
Obesity (Silver Spring); 2017 Mar; 25(3):561-571. PubMed ID: 28145056
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
[TBL] [Abstract][Full Text] [Related]
11. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
12. Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity.
Lee ES; Kwon MH; Kim HM; Woo HB; Ahn CM; Chung CH
Metabolism; 2020 Feb; 103():154015. PubMed ID: 31758951
[TBL] [Abstract][Full Text] [Related]
13. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
Lee MR; Yang HJ; Park KI; Ma JY
Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
[TBL] [Abstract][Full Text] [Related]
14. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
[TBL] [Abstract][Full Text] [Related]
16. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
[TBL] [Abstract][Full Text] [Related]
17. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
18. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
19. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
20. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
